Daniel P Davis, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 315 W Madison Ave, Chester, MT 59522 Phone: 406-759-5181 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced the availability of its AccuType® IL28B test for aiding in the prediction of patient response to peginterferon alpha-based therapy for hepatitis C virus (HCV) infection.
Although current treatments for iron-deficiency anemia can be effective, they commonly fail because pediatric patients do not complete the treatment and might experience adverse effects related to using high doses.
Emergex Vaccines Holding Limited, a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, today announced that it has entered into an agreement with the George Mason University, based in Virginia, in the United States.
Salix Pharmaceuticals, Ltd. today announced that based on a telephone conversation with the U.S. Food and Drug Administration held last evening, the Company anticipates receiving a Complete Response Letter on or before the March 7, 2011 PDUFA goal date for the supplemental New Drug Application for XIFAXAN 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome and IBS-related bloating.
› Verified 4 days ago